Kevesy

Levetiracetam, the active ingredient in Kevesy, is a pyrrolidine derivative presented as an intravenous solution for intravenous use. It treats partial‑onset, generalized tonic‑clonic and myoclonic seizures in patients requiring acute seizure control.

GNH USA supplies Kevesy as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic drug used to manage several seizure types.

Partial‑onset seizures: reduces seizure frequency and severity in focal epilepsy. Generalized tonic‑clonic seizures: provides rapid control of convulsive episodes. Myoclonic seizures: helps prevent sudden muscle jerks associated with juvenile myoclonic epilepsy.

Levetiracetam may cause a range of adverse reactions, most of which are mild to moderate.

Common Side Effects: - Headache: mild to moderate intensity. - Fatigue: generalized tiredness. - Dizziness: sensation of light‑headedness. - Somnolence: increased sleepiness. - Nausea: occasional upset stomach. - Irritability: mood changes or agitation.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, or anaphylaxis. - Stevens‑Johnson syndrome: rare skin disorder. - Blood dyscrasias: neutropenia or thrombocytopenia. - Suicidal ideation: thoughts of self‑harm. - Respiratory depression: especially with concomitant depressants. - Hepatic injury: elevated liver enzymes.

When using Kevesy, clinicians should consider several safety aspects.

Renal impairment: adjust dosing according to renal function. Hepatic impairment: monitor liver enzymes regularly. Pregnancy: use only if potential benefit justifies the risk. Concomitant CNS depressants: observe for additive sedation. Psychiatric symptoms: watch for mood changes or aggression. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Levetiracetam can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Incompatible IV solutions: do not mix with calcium‑containing infusions. - Live vaccines: may diminish vaccine efficacy.

Moderate Interactions (Monitor Closely): - Enzyme‑inducing antiepileptics (e.g., carbamazepine, phenytoin): may lower levetiracetam levels. - CNS depressants (e.g., benzodiazepines, alcohol): increase sedation risk. - Antidepressants (e.g., SSRIs): monitor for mood alterations. - Renal‑clearing drugs (e.g., aminoglycosides): assess renal function.